{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:24:16Z","timestamp":1791404656725,"version":"4.3.3"},"update-to":[{"DOI":"10.1002\/14651858.cd013211","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000}}],"reference-count":330,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013211.pub2","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:28:15Z","timestamp":1611361695000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of atorvastatin on testosterone levels"],"prefix":"10.1002","volume":"2021","author":[{"given":"Muhammad Ismail","family":"Shawish","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pharmacology and Therapeutics; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahador","family":"Bagheri","sequence":"additional","affiliation":[{"name":"Cancer Research Center; Semnan University of Medical Sciences; Semnan Iran"},{"name":"Center for Molecular Cardiology; University of Zurich; Schlieren Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya M","family":"Musini","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pharmacology and Therapeutics; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pharmacology and Therapeutics; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pharmacology and Therapeutics; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.13005\/bpj\/1046","article-title":"The effect of atorvastatin on the ovarian arterial blood flow and serum androgen level in PCOS patient","volume":"9","author":"Akbari","year":"2016","journal-title":"Biomedical and Pharmacology Journal"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.archger.2014.07.006","article-title":"Effects of atorvastatin on bone mineral density (BMD) and bone metabolism in elderly males with osteopenia and mild dyslipidemia: A 1-year randomized trial","volume":"59","author":"Chen","year":"2014","journal-title":"Archives of Gerontology & Geriatrics"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11255-012-0126-z","article-title":"Effect of atorvastatin on erectile functions in comparison with regular tadalafil use. A prospective single-blind study","volume":"44","author":"Gokce","year":"2012","journal-title":"International Urology & Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD013211.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1210\/jc.2013-2674","article-title":"Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study","volume":"98","author":"Puurunen","year":"2013","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.fertnstert.2010.11.040","article-title":"Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial","volume":"95","author":"Raja-Khan","year":"2011","journal-title":"Fertility & Sterility"},{"issue":"8","key":"10.1002\/14651858.CD013211.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EC-17-0217","article-title":"The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome","volume":"6","author":"Sathyapalan","year":"2017","journal-title":"Endocrine Connections"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/jc.2008-1750","article-title":"The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study","volume":"94","author":"Sathyapalan","year":"2009","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"Pt 1","key":"10.1002\/14651858.CD013211.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1258\/acb.2011.011071","article-title":"Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study","volume":"49","author":"Sathyapalan","year":"2012","journal-title":"Annals of Clinical Biochemistry"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/eurheartj\/ehp006","article-title":"Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study","volume":"30","author":"Almroth","year":"2009","journal-title":"European Heart Journal"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013211.pub2-BIB0010|cit10","first-page":"108","article-title":"Effect of atorvastatin compared with placebo on cerebrovascular end points in patients with previous stroke or transient ischemic attack - The SPARCL Study","volume":"9","author":"Amarenco","year":"1999","journal-title":"Cerebrovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD013211.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/STROKEAHA.107.493106","article-title":"Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial","volume":"38","author":"Amarenco","year":"2007","journal-title":"Stroke"},{"issue":"4 SUPPL. A","key":"10.1002\/14651858.CD013211.pub2-BIB0013|cit13","first-page":"S109","article-title":"The role of statins in the prevention of stroke","volume":"3","author":"Amarenco","year":"2007","journal-title":"Archives of Medical Science"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.atherosclerosis.2008.09.008","article-title":"Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial","volume":"204","author":"Amarenco","year":"2009","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1161\/STROKEAHA.108.534107","article-title":"Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes","volume":"40","author":"Amarenco","year":"2009","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0016|cit16","first-page":"331","article-title":"Relative and cumulative effects of lipid and blood pressure control in the stroke prevention by aggressive reduction in cholesterol levels trial","volume":"73","author":"Amarenco","year":"2009","journal-title":"Neurology EMT - stroke prevention blood pressure regulation neurology risk patient density ischemic heart disease transient ischemic attack hazard ratio cholesterol lipid high density lipoprotein low density lipoprotein triacylglycerol placebo atorvastat"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/STROKEAHA.109.564781","article-title":"Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial","volume":"41","author":"Amarenco","year":"2010","journal-title":"Stroke; a Journal of Cerebral Circulation"},{"issue":"10","key":"10.1002\/14651858.CD013211.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1161\/STROKEAHA.114.005832","article-title":"Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial","volume":"45","author":"Amarenco","year":"2014","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1755-5922.2008.00064.x","article-title":"Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with type 2 diabetes mellitus","volume":"26","author":"Amudha","year":"2008","journal-title":"Cardiovascular Therapeutics"},{"issue":"29","key":"10.1002\/14651858.CD013211.pub2-BIB0020|cit20","first-page":"30","article-title":"Lipid lowering - New study with atorvastatin","volume":"138","year":"1998","journal-title":"Deutsche Apotheker Zeitung"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jama.1996.03530260042029","article-title":"Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia","volume":"275","author":"Bakker-Arkema","year":"1996","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jacl.2016.09.004","article-title":"The effects of statin treatment on adrenal and sexual function and nitric oxide levels in hypercholesterolemic male patients treated with a statin","volume":"10","author":"Baspinar","year":"2016","journal-title":"Journal of Clinical Lipidology"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00198-004-1598-1","article-title":"Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women","volume":"15","author":"Berthold","year":"2004","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1155\/2012\/895326","article-title":"Improving total-cholesterol\/HDL-cholesterol ratio results in an endothelial dysfunction recovery in peripheral artery disease patients","volume":"2012","author":"Bleda","year":"2012","journal-title":"Cholesterol"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ahj.2008.09.022","article-title":"Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients","volume":"157","author":"Bloomfield","year":"2009","journal-title":"American Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.atherosclerosis.2015.05.034","article-title":"Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood","volume":"241","author":"Braamskamp","year":"2015","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/1008-682X.123678","article-title":"The role of statins in erectile dysfunction: a systematic review and meta-analysis","volume":"16","author":"Cai","year":"2014","journal-title":"Asian Journal of Andrology"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-2362.2002.01001.x","article-title":"Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity","volume":"32","author":"Chan","year":"2002","journal-title":"European Journal of Clinical Investigation"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0022-2275(20)30112-7","article-title":"Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test","volume":"43","author":"Chan","year":"2002","journal-title":"Journal of Lipid Research"},{"issue":"8","key":"10.1002\/14651858.CD013211.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2337\/diabetes.51.8.2377","article-title":"Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia","volume":"51","author":"Chan","year":"2002","journal-title":"Diabetes"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ajcn\/84.1.37","article-title":"Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity","volume":"84","author":"Chan","year":"2006","journal-title":"American Journal of Clinical Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0032|cit32","first-page":"150","article-title":"Ethnic variations in lipid-lowering in response to a statin (EVIREST): a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)","volume":"21","author":"Chapman","year":"2011","journal-title":"Ethnicity & Disease"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2337\/db08-1688","article-title":"Muscle microvascular dysfunction in central obesity is related to muscle insulin insensitivity but is not reversed by high-dose statin treatment","volume":"58","author":"Clough","year":"2009","journal-title":"Diabetes"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ajh.2008.325","article-title":"Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia","volume":"22","author":"Cohn","year":"2009","journal-title":"American Journal of Hypertension"},{"issue":"11","key":"10.1002\/14651858.CD013211.pub2-BIB0035|cit35","first-page":"682","article-title":"Cholesterol lowering with atorvastatin for the primary prevention of cardiovascular disease in diabetic adults","volume":"11","author":"Colhoun","year":"2004","journal-title":"Journal of Clinical Outcomes Management"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1807-59322008000500004","article-title":"Vascular and metabolic response to statin in the mildly hypertensive hypercholesterolemic elderly","volume":"63","author":"Crisostomo","year":"2008","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"982.e1","DOI":"10.1016\/j.ahj.2006.08.009","article-title":"Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial","volume":"152","author":"Cubeddu","year":"2006","journal-title":"American Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0038|cit38","first-page":"786","article-title":"[Effect of atorvastatin on endothelium-dependent vasodilatation function in patients with essential hypertension complicated by hyperlipidemia]","volume":"27","author":"Cui","year":"2006","journal-title":"Wuhan Daxue Xuebao"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2337\/db05-1685","article-title":"Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?","volume":"55","author":"Dallinga-Thie","year":"2006","journal-title":"Diabetes"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00125-006-0261-0","article-title":"Plasma apolipoprotein A5 and triglycerides in type 2 diabetes","volume":"49","author":"Dallinga-Thie","year":"2006","journal-title":"Diabetologia"},{"issue":"3 PG - 268-275","key":"10.1002\/14651858.CD013211.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0002-9149(01)02226-3","article-title":"Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia","volume":"89","author":"Davidson","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"21","key":"10.1002\/14651858.CD013211.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/eurheartj\/ehq133","article-title":"Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?","volume":"31","author":"Deanfield","year":"2010","journal-title":"European Heart Journal"},{"issue":"8","key":"10.1002\/14651858.CD013211.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/diacare.24.8.1335","article-title":"The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia","volume":"24","author":"Diabetes Atorvastin Lipid Intervention Study Group","year":"2001","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2796.2005.01484.x","article-title":"Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial","volume":"257","author":"Diepeveen","year":"2005","journal-title":"Journal of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.ajkd.2007.03.003","article-title":"A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD","volume":"49","author":"Dogra","year":"2007","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1210\/jc.2003-031116","article-title":"The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes","volume":"89","author":"Economides","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1 SUPPL 1","key":"10.1002\/14651858.CD013211.pub2-BIB0047|cit47","article-title":"Comparing the effects of atorvastatin and vitamin E on endothelial function of sildenafil non-responders","volume":"28","author":"Elkawy","year":"2014","journal-title":"FASEB Journal"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0048|cit48","unstructured":"A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter Study of the Efficacy, Safety, and Tolerability of Fixed Combination Torcetrapib\/Atorvastatin Administered Orally, Once Daily for 6 Months, Compared to Atorvastatin Alone or Placebo, in Subjects With Mixed Dyslipidemia (Frederickson Types IIa and IIb). - N\/A http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2004-000139-27-SE 2004"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.atherosclerosis.2004.05.030","article-title":"Progesterone abolishes estrogen and\/or atorvastatin endothelium dependent vasodilatory effects","volume":"177","author":"Faludi","year":"2004","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0735-1097(02)01717-5","article-title":"Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension","volume":"39","author":"Ferrier","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"issue":"14","key":"10.1002\/14651858.CD013211.pub2-BIB0051|cit51","first-page":"14","article-title":"Cholesterol reduction and artery compliance in hypertension","volume":"19","author":"Ferrier","year":"2002","journal-title":"Cardiology Review"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.amjhyper.2004.06.005","article-title":"Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance","volume":"17","author":"Fogari","year":"2004","journal-title":"American Journal of Hypertension"},{"issue":"10","key":"10.1002\/14651858.CD013211.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00228-006-0176-1","article-title":"Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients","volume":"62","author":"Fogari","year":"2006","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0002-9149(02)02659-0","article-title":"Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus","volume":"90","author":"Freed","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00380-007-1008-7","article-title":"Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia","volume":"23","author":"Ge","year":"2008","journal-title":"Heart and Vessels"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1463-1326.2000.00106.x","article-title":"Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia","volume":"2","author":"Gentile","year":"2000","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0057|cit57","unstructured":"A 16-Week Randomized, Double-Blind, Parallel-Group Study to Evaluate the Safety and Efficacy of Hypolipidemic Therapy with an HMGCoA Reductase Inhibitor (Atorvastatin) in Type 2 Diabetes Mellitus Patients Treated with Rosiglitazone (BRL 49653C) 4mg bd Protocol No. 49653\/108 2000"},{"issue":"12","key":"10.1002\/14651858.CD013211.pub2-BIB0058|cit58","first-page":"17","article-title":"Comparison of the effects of carbohydrate metabolism compensation and atorvastatin treatment on lipid metabolism and c-reactive protein in type 2 diabetes mellitus","volume":"80","author":"Glinkina","year":"2008","journal-title":"Terapevticheskii Arkhiv"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1161\/STROKEAHA.107.513747","article-title":"Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study","volume":"39","author":"Goldstein","year":"2008","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD013211.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1161\/STROKEAHA.109.557330","article-title":"Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial","volume":"40","author":"Goldstein","year":"2009","journal-title":"Stroke; a Journal of Cerebral Circulation"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/VHRM.S7710","article-title":"Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine\/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial","volume":"6","author":"Grimm","year":"2010","journal-title":"Vascular Health and Risk Management"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3892\/etm.2012.722","article-title":"Effects of atorvastatin on serum lipids, serum inflammation and plaque morphology in patients with stable atherosclerotic plaques","volume":"4","author":"Guo","year":"2012","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.diabet.2010.08.006","article-title":"Effect of atorvastatin on lipoprotein (a) and interleukin-10: a randomized placebo-controlled trial","volume":"37","author":"Hernandez","year":"2010","journal-title":"Diabetes & Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00125-008-1179-5","article-title":"Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial","volume":"52","author":"Holman","year":"2009","journal-title":"Diabetologia"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/00365590510031255","article-title":"Safety and efficacy of atorvastatin in patients with severe renal dysfunction","volume":"39","author":"Holmberg","year":"2005","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD013211.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cardfail.2011.07.008","article-title":"Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial","volume":"17","author":"Horwich","year":"2011","journal-title":"Journal of Cardiac Failure"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0021-9150(01)00437-3","article-title":"Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively","volume":"158","author":"Hunninghake","year":"2001","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjcard.2006.01.055","article-title":"Effect of atorvastatin (10 mg\/day) on glucose metabolism in patients with the metabolic syndrome","volume":"98","author":"Huptas","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.18565\/cardio.2014.2.37-42","article-title":"Dose-dependent effect of atorvastatin on erectile function and androgen status in men with high cardiovascular risk","volume":"54","author":"Iakovenko","year":"2014","journal-title":"Kardiologiia"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0070|cit70","first-page":"947","article-title":"[Combination therapy with angiotensin receptor blocker (ARB) plus atorvastatin reduced proteinuria in type 2 diabetic patients with diabetic nephropathy]","volume":"32","author":"Inukai","year":"2011","journal-title":"Therapeutic Research"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0071|cit71","unstructured":"The effect of atorvastatin on biochemical and hemostatic profile of patients with polycystic ovary syndrome http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT201208299626N1 2012"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/fcp.12301","article-title":"Atorvastatin attenuates testosterone-induced benign prostatic hyperplasia in rats: role of peroxisome proliferator-activated receptor-gamma and cyclo-oxygenase-2","volume":"31","author":"Ishola","year":"2017","journal-title":"Fundamental & Clinical Pharmacology"},{"issue":"3-5","key":"10.1002\/14651858.CD013211.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jsbmb.2011.11.001","article-title":"Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women","volume":"128","author":"Issa","year":"2012","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0074|cit74","first-page":"142","article-title":"Randomised study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia","volume":"105","author":"Jayaram","year":"2007","journal-title":"Journal of the Indian Medical Association"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0002-9149(97)00092-1","article-title":"Efficacy of atorvastatin in primary hypercholesterolemia. Japan Cholesterol Lowering Atorvastatin Study (J-CLAS) Group","volume":"79","year":"1997","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1345\/aph.1K407","article-title":"Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients","volume":"42","author":"Joy","year":"2008","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0077|cit77","unstructured":"Effects of lipid lowering by atorvastatin on carotid atherosclerotic plaque (ACAP) study: a randomized trial for analysis of qualitative change in carotid atherosclerrotic plaque with IB echo and Black Blood MRI http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000001114 2008"},{"issue":"1-3","key":"10.1002\/14651858.CD013211.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.regpep.2011.05.008","article-title":"Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk","volume":"170","author":"Kadoglou","year":"2011","journal-title":"Regulatory Peptides"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.atherosclerosis.2009.03.028","article-title":"Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall","volume":"206","author":"Kajimoto","year":"2009","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00380-005-0901-1","article-title":"The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol","volume":"21","author":"Kanadasi","year":"2006","journal-title":"Heart and Vessels"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1517\/14728220903023866","article-title":"Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: Modification by triglycerides and cholesteryl ester transfer protein","volume":"13","author":"Kappelle","year":"2009","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbalip.2009.09.021","article-title":"Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets","volume":"1801","author":"Kappelle","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1559-4572.2008.07967.x","article-title":"High-dose atorvastatin after stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators","volume":"3","author":"Karam","year":"2008","journal-title":"Journal of the Cardiometabolic Syndrome"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jjcc.2008.12.002","article-title":"Atorvastatin might improve ventricular electrostability and decelerate the deterioration of renal function in patients with heart failure and diabetes mellitus","volume":"53","author":"Kishi","year":"2009","journal-title":"Journal of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/art.40892","article-title":"Trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis (TRACE RA): a multicenter, randomized, placebo controlled trial","volume":"71","author":"Kitas","year":"2019","journal-title":"Arthritis & Rheumatology"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/dc05-2415","article-title":"Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)","volume":"29","author":"Knopp","year":"2006","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1002\/14651858.CD013211.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jacc.2005.02.052","article-title":"Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia","volume":"45","author":"Koh","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD013211.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","article-title":"Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients","volume":"55","author":"Koh","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2125.2006.02832.x","article-title":"Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients","volume":"63","author":"Kom G","year":"2007","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1463-1326.2007.00798.x","article-title":"Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension","volume":"10","author":"Konduracka","year":"2008","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"10","key":"10.1002\/14651858.CD013211.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/dc10-0272","article-title":"Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes","volume":"33","author":"Krysiak","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-0034-1394400","article-title":"The effect of atorvastatin and atorvastatin-ezetimibe combination therapy on androgen production in hyperandrogenic women with elevated cholesterol levels","volume":"123","author":"Krysiak","year":"2014","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.pharep.2015.08.009","article-title":"The effect of testosterone on cardiometabolic risk factors in atorvastatin-treated men with late-onset hypogonadism","volume":"68","author":"Krysiak","year":"2016","journal-title":"Pharmacological Reports: PR"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00392-003-0967-7","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cariac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial","volume":"92","author":"Kubler","year":"2003","journal-title":"Zeitschrift fur Kardiologie"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0095|cit95","first-page":"21","article-title":"Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation","volume":"50","author":"Kuznetsova","year":"2010","journal-title":"Kardiologiia"},{"issue":"8","key":"10.1002\/14651858.CD013211.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1194\/jlr.M700067-JLR200","article-title":"Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism","volume":"48","author":"Lamon-Fava","year":"2007","journal-title":"Journal of Lipid Research"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/STROKEAHA.108.540088","article-title":"Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease","volume":"40","author":"Lavallee","year":"2009","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2004.01.016","article-title":"The effect of high dose atorvastatin therapy on lipids and lipoprotein subfractions in overweight patients with type 2 diabetes","volume":"174","author":"Lawrence","year":"2004","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0099|cit99","first-page":"357","article-title":"The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value","volume":"15","author":"Lewandowski","year":"2008","journal-title":"Cardiology Journal"},{"issue":"34","key":"10.1002\/14651858.CD013211.pub2-BIB0100|cit100","first-page":"2399","article-title":"[Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification]","volume":"86","author":"Li","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0101|cit101","first-page":"736","article-title":"Influence of atorvastatin on ischemic adverse events following cerebral middle artery stent implantation: A 12-month follow-up in 24 cases. [Chinese]","volume":"14","author":"Li","year":"2010","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5414\/CNP62287","article-title":"Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study","volume":"62","author":"Lins","year":"2004","journal-title":"Clinical Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10557-009-6186-3","article-title":"Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation","volume":"23","author":"Liu","year":"2009","journal-title":"Cardiovascular Drugs & Therapy"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/cen.12113","article-title":"Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial","volume":"79","author":"Loughrey","year":"2013","journal-title":"Clinical Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"e32894","DOI":"10.1371\/journal.pone.0032894","article-title":"Statins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trial","volume":"7","author":"Macchia","year":"2012","journal-title":"PloS one"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ahj.2004.07.041","article-title":"Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study","volume":"149","author":"Macin","year":"2005","journal-title":"American Heart Journal"},{"issue":"12","key":"10.1002\/14651858.CD013211.pub2-BIB0107|cit107","first-page":"742","article-title":"Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control","volume":"6","author":"Magen","year":"2004","journal-title":"Israel Medical Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0108|cit108","first-page":"71","article-title":"The REVEAL study","volume":"19","author":"Maggioni","year":"2018","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0109|cit109","first-page":"50","article-title":"Effectiveness, safety, and endothelial function effects of atorvastatin lipid-lowering therapy in coronary heart disease patients undergoing percutaneous coronary intervention","volume":"6","author":"Mal'gina","year":"2007","journal-title":"Cardiovascular Therapy and Prevention"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1742-1241.2010.02412.x","article-title":"A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors","volume":"64","author":"Malekzadeh","year":"2010","journal-title":"International Journal of Clinical Practice"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/dmrr.402","article-title":"Effects of Atorvastatin on LDL sub-fractions and peroxidation in type 1 diabetic patients: a randomised double-blind placebo-controlled study","volume":"19","author":"Manuel Y Keenoy","year":"2003","journal-title":"Diabetes\/Metabolism Research Reviews"},{"issue":"10","key":"10.1002\/14651858.CD013211.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0022-2275(20)37137-6","article-title":"Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia","volume":"38","author":"Marais","year":"1997","journal-title":"Journal of Lipid Research"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00005344-200011000-00011","article-title":"Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women","volume":"36","author":"Marchesi","year":"2000","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"e17554","DOI":"10.1371\/journal.pone.0017554","article-title":"Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial","volume":"6","author":"Martin","year":"2011","journal-title":"PloS one"},{"issue":"8","key":"10.1002\/14651858.CD013211.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/01.STR.0000174289.34110.b0","article-title":"Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month","volume":"36","author":"Martin-Ventura","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3476(03)00186-0","article-title":"Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial","volume":"143","author":"McCrindle","year":"2003","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1139\/Y07-043","article-title":"Effect of pioglitazone and its combination with statins in coronary artery disease patients with hyperinsulinemia","volume":"85","author":"Mehta","year":"2007","journal-title":"Canadian Journal of Physiology & Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.25011\/cim.v32i6.10658","article-title":"Assessment of arterial stiffness affected by atorvastatin in coronary artery disease using pulse wave velocity","volume":"32","author":"Meng","year":"2009","journal-title":"Clinical & Investigative Medicine. Medecine Clinique et Experimentale"},{"issue":"8","key":"10.1002\/14651858.CD013211.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1524-6175.2006.05636.x","article-title":"Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial","volume":"8","author":"Messerli","year":"2006","journal-title":"Journal of Clinical Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.eururo.2007.02.032","article-title":"Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement","volume":"52","author":"Mills","year":"2007","journal-title":"European Urology"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2265.2005.02273.x","article-title":"The effect of atorvastatin on serum lipoproteins in acromegaly","volume":"62","author":"Mishra","year":"2005","journal-title":"Clinical Endocrinology"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0122|cit122","first-page":"471","article-title":"The influence of atorvastatin therapy on myocardial ischemia in patients with stable angina pectoris. [Polish]","volume":"12","author":"Moga","year":"2005","journal-title":"Folia Cardiologica"},{"issue":"12","key":"10.1002\/14651858.CD013211.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.0000090686.57897.F5","article-title":"Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease","volume":"108","author":"Mohler","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4168\/aair.2012.4.5.290","article-title":"Evaluation of atorvastatin for the treatment of patients with asthma: A double-blind randomized clinical trial","volume":"4","author":"Moini","year":"2012","journal-title":"Allergy, Asthma & Immunology Research"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0125|cit125","first-page":"93","article-title":"Early effects of lipid lowering treatment in subjects with metabolic syndrome and acute coronary syndromes","volume":"3","author":"Monteiro","year":"2008","journal-title":"International Journal of Atherosclerosis"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1013314227857","article-title":"Short term effect of atorvastatin and vitamin E on serum levels of C3, a sensitive marker of the risk of myocardial infarction in men","volume":"15","author":"Muscari","year":"2001","journal-title":"Cardiovascular Drugs & Therapy"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0002-9149(97)00092-1","article-title":"Efficacy of atorvastatin in primary hypercholesterolemia","volume":"79","author":"Nakamura","year":"1997","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2006.08.028","article-title":"Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia","volume":"193","author":"Nakamura","year":"2007","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0022-2275(20)37432-0","article-title":"Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin","volume":"38","author":"Naoumova","year":"1997","journal-title":"Journal of Lipid Research"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1365-2362.1999.00475.x","article-title":"Effect of inhibiting HMG-CoA reductase on 7alpha-hydroxy-4-cholesten-3-one, a marker of bile acid synthesis: Contrasting findings in patients with and without prior up-regulation of the latter pathway","volume":"29","author":"Naoumova","year":"1999","journal-title":"European Journal of Clinical Investigation"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1365-2362.2003.01105.x","article-title":"Treatment with atorvastatin alters the ratio of interleukin-12\/interleukin-10 gene expression [corrected]","volume":"33","author":"Naoumova","year":"2003","journal-title":"European Journal of Clinical Investigation"},{"issue":"8","key":"10.1002\/14651858.CD013211.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-2003-41805","article-title":"Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia","volume":"35","author":"Nawawi","year":"2003","journal-title":"Hormone & Metabolic Research"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.ATV.15.5.678","article-title":"Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor","volume":"15","author":"Nawrocki","year":"1995","journal-title":"Arterosclerosis, Thrombosis & Vascular Biology"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0134|cit134","unstructured":"A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis https:\/\/clinicaltrials.gov\/show\/nct00433823"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0135|cit135","unstructured":"Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition https:\/\/clinicaltrials.gov\/show\/nct00522158"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0136|cit136","unstructured":"Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease Https:\/\/clinicaltrials.gov\/show\/nct00603590 2008 PG -"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0137|cit137","unstructured":"Atorvastatin Calcium in Preventing Metabolic Syndrome in Patients With Prostate Cancer Receiving Long-Term Androgen-Deprivation Therapy https:\/\/clinicaltrials.gov\/show\/nct01555632"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0138|cit138","unstructured":"LIpitor and biGuanide to Androgen Delay Trial https:\/\/clinicaltrials.gov\/show\/nct02497638"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0139|cit139","unstructured":"Type 2 Diabetic Patients Maintained on Statin Therapy Https:\/\/clinicaltrials.gov\/show\/nct03784703 2018 PG -"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0140|cit140","unstructured":"Effect of Atorvastatin on Subclinical Atherosclerosis https:\/\/clinicaltrials.gov\/show\/NCT04101136 2019 PG -"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1540-8167.2010.01925.x","article-title":"Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial)","volume":"22","author":"Negi","year":"2011","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.atherosclerosis.2010.09.013","article-title":"Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial","volume":"213","author":"Neil","year":"2010","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1751-7176.2008.00058.x","article-title":"The use of a single-pill calcium channel blocker\/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter study","volume":"11","author":"Neutel","year":"2009","journal-title":"Journal of Clinical Hypertension"},{"issue":"19","key":"10.1002\/14651858.CD013211.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2011.1649","article-title":"Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial","volume":"306","author":"Nicholls","year":"2011","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0145|cit145","first-page":"21","article-title":"The use of atorvastatin in patients with rheumatoid arthritis with hyperlipidemia","volume":"49","author":"Nikitina","year":"2009","journal-title":"Kardiologiia"},{"issue":"12","key":"10.1002\/14651858.CD013211.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jama.297.12.1362","article-title":"Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials","volume":"297","author":"Nissen","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/01.ATV.21.5.832","article-title":"Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia","volume":"21","author":"O'Neill","year":"2001","journal-title":"Arteriosclerosis, Thrombosis, & Vascular Biology"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.CIR.0000140261.58966.A4","article-title":"Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study","volume":"110","author":"Okazaki","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD013211.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"589","DOI":"10.5414\/CPP42589","article-title":"Effect of monthly atorvastatin treatment on hemostasis","volume":"42","author":"Okopien","year":"2004","journal-title":"International Journal of Clinical Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.fjc.0000156821.50457.32","article-title":"Effect of monthly atorvastatin and fenofibrate treatment on monocyte chemoattractant protein-1 release in patients with primary mixed dyslipidemia","volume":"45","author":"Okopien","year":"2005","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00001721-200206000-00007","article-title":"High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes","volume":"13","author":"Olivotti","year":"2002","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0002-9149(01)01727-1","article-title":"Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia","volume":"88","author":"Olsson","year":"2001","journal-title":"American Journal of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/eurheartj\/ehi186","article-title":"High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial","volume":"26","author":"Olsson","year":"2005","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.amjcard.2006.09.111","article-title":"Effects of high-dose atorvastatin in patients > or =65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with aggressive cholesterol lowering [MIRACL] study)","volume":"99","author":"Olsson","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD013211.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1194\/jlr.P029223","article-title":"Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome","volume":"53","author":"Ooi","year":"2012","journal-title":"Journal of Lipid Research"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0009-8981(01)00549-6","article-title":"Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients","volume":"311","author":"Oranje","year":"2001","journal-title":"Clinica Chimica Acta"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2710.2003.00540.x","article-title":"Hormonal changes with cholesterol reduction: a double-blind pilot study","volume":"29","author":"Ormiston","year":"2004","journal-title":"Journal of Clinical Pharmacy & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/HYPERTENSIONAHA.109.138248","article-title":"Arterial destiffening with atorvastatin in overweight and obese middle-aged and older adults","volume":"54","author":"Orr","year":"2009","journal-title":"Hypertension"},{"issue":"11","key":"10.1002\/14651858.CD013211.pub2-BIB0159|cit159","first-page":"1933","article-title":"LDL-cholesterol lowering therapy by atorvastatin have an impact on the carotid intima-media thickness in the hypercholesterolemia patient with type 2 diabetes","volume":"29","author":"Oshima","year":"2008","journal-title":"Therapeutic Research"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/bjo.2006.098285","article-title":"Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy","volume":"91","author":"Ozkiris","year":"2007","journal-title":"British Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD013211.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/0091270007302169","article-title":"Atorvastatin treatment and vaccination efficacy","volume":"47","author":"Packard","year":"2007","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00005344-200302000-00010","article-title":"Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors","volume":"41","author":"Paiva","year":"2003","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"Paiva","year":"2005","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1100\/tsw.2011.43","article-title":"Results of a randomized,open-label,clinical trial investigating the effects of supplementation with Heracleumpersicum extract as an adjunctive therapy for dyslipidemia","volume":"11","author":"Panahi","year":"2011","journal-title":"Thescientificworldjournal"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0021-9150(99)00352-4","article-title":"Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients","volume":"150","author":"Paolisso","year":"2000","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.atherosclerosis.2006.10.033","article-title":"Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatment","volume":"196","author":"Papathanasiou","year":"2008","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/ATVBAHA.107.157172","article-title":"Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2","volume":"28","author":"Parini","year":"2008","journal-title":"Arteriosclerosis, Thrombosis, & Vascular Biology"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.atherosclerosis.2011.09.049","article-title":"Atorvastatin increases exercise leg blood flow in healthy adults","volume":"219","author":"Parker","year":"2011","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","article-title":"Effect of statins on skeletal muscle function","volume":"127","author":"Parker","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0021-9150(01)00410-5","article-title":"Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner","volume":"158","author":"Pedro-Botet","year":"2001","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0171|cit171","first-page":"32","article-title":"Atorvastatin and folic acid improve cardiac function and inhibit ventricular remodeling in chronic heart failure patients with hyperhomocysteinemia","volume":"26","author":"Peng","year":"2018","journal-title":"Journal of the Hong Kong College of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/ard.2010.136762","article-title":"Lupus Atherosclerosis Prevention Study (LAPS)","volume":"70","author":"Petri","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0173|cit173","unstructured":"The atorvastatin efficacy and safety study in diabetic patients to determine starting dose for effectively reducing lipids. (The ADSL study) Protocol No. A2581080 2003"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0174|cit174","unstructured":"A Multi-National, Prospective Randomized Double-Blind, Multi-Center, Placebo-Controlled Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin In The Treatment Of Concurrent Hypertension And Hyperlipidemia - Th Protocol No. A3841003 2003"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0175|cit175","unstructured":"Double-blind, placebo-controlled, dose ranging trial to evaluate the efficacy of atorvastatin on bone mineral density and markers for bone turnover in postmenopausal women with dyslipidemia and at risk for osteoporosis Protocol No. A2581049 2003"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0176|cit176","unstructured":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled And Open-Label Evaluation Of The Safety And Efficacy Of Dual Therapy With Atorvastatin Plus Amlodipine When Compared To Either Therapy Alone In The Treatment Of Patients With Simultaneous Hyperlipidemia And Hypertension. (The Avalon Study) Protocol no. A3841001 2003"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0177|cit177","unstructured":"A 4-year, double-blind, randomized, placebo-controlled, study of atorvastatin as prevention of CHD endpoints in patients with (Type II) non-insulin dependent diabetes mellitus. (ASPEN) Protocol No. 0981-071 2004"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0178|cit178","unstructured":"Impact Of Atorvastatin On The Distribution, Composition And Metabolism Of LDL (Low Density Lipoprotein) And HDL (High Density Lipoprotein) Subfractions: A Double-Blind Placebo-Controlled Phase IV Study With Patients Suffering From Combined Hyperlipidemia And Diabetes - Atorvastatin And LDL Profile In NIDDM (ALPIN Study) https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00640549 2004"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0179|cit179","unstructured":"A multicenter, double blind, randomized, placebo controlled parallel group study to assess the efficacy and safety of atorvastatin in the treatment of men with lower urinary tract symptoms and urinary outflow obstruction associated with benign prostatic enlargement Protocol No. A2581125 2004"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0180|cit180","unstructured":"Phase 2, multi-center, double-blind, placebo-controlled, randomized, parallel group, dose response study of the safety and efficacy of CP-529,414 combination with open-label atorvastatin once daily (QD) for 12 weeks in subjects with hypercholesterolemia and without overt cardiovascular disease Pfizer 2005"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0181|cit181","unstructured":"A multi-center, randomized, open-label study to evaluate efficacy and safety of dual therapy with atorvastatin plus amlodipine when compared to amlodipine therapy alone in the treatment of subjects with concurrent hyperlipidemia and hypertension Protocol No. A3841026 2006"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0182|cit182","unstructured":"A phase 3, double-blind, placebo-controlled, randomized, parallel group, multicenter study of the efficacy, safety and tolerability of fixed combination torcetrapib\/atorvastatin administered orally, once daily for 6 months, compared to atorvastatin alone or placebo, in subjects with mixed dyslipidemia (Frederickson types IIa and IIb) Protocol No. A5091018 2006"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0183|cit183","unstructured":"Carotid Atorvastatin Study in Hyperlipidemic Post-MEnopausal Women: a Randomised Evaluation of Atorvastatin Versus Placebo (CASHMERE). Protocol A2581051 Http:\/\/pdf.clinicalstudyresults.org\/documents\/company-study_2902_0.pdf 2007 1 11"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0184|cit184","unstructured":"Atorvastatin and cardiovascular complications in Type II diabetes dialysis patients. The German Diabetes Dialysis Study: 4D Study. Determination of Cardiovascular endpoints in NIDDM dialysis patients Protocol No. CT-981-423-239 2009"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0185|cit185","unstructured":"A double-blind, placebo-controlled study of atorvastatin as prevention of CHD in high risk patients with non-insulin-dependent diabetes mellitus(CARDS) Protocol No. 0981-430-102 2010"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/B:MCBI.0000028739.10079.0b","article-title":"Comparison of raloxifene and atorvastatin effects on serum lipids composition of healthy post-menopausal women","volume":"261","author":"Piperi","year":"2004","journal-title":"Molecular & Cellular Biochemistry"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/ar3402","article-title":"Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study","volume":"13","author":"Plazak","year":"2011","journal-title":"Arthritis Research & Therapy"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7827-12-65","article-title":"Evaluation of atorvastatin efficacy and toxicity on spermatozoa, accessory glands and gonadal hormones of healthy men: A pilot prospective clinical trial","volume":"12","author":"Pons-Rejraji","year":"2014","journal-title":"Reproductive Biology & Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1053\/meta.2002.30510","article-title":"Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose\/type 2 diabetes","volume":"51","author":"Pontrelli","year":"2002","journal-title":"Metabolism: Clinical & Experimental"},{"issue":"12","key":"10.1002\/14651858.CD013211.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/0091270007307879","article-title":"A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial","volume":"47","author":"Preston","year":"2007","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0021-9150(99)00435-9","article-title":"Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia","volume":"150","author":"Raal","year":"2000","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.atherosclerosis.2003.07.011","article-title":"Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia","volume":"171","author":"Raal","year":"2003","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1002\/14651858.CD013211.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.jhh.1001470","article-title":"Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study","volume":"16","author":"Raison","year":"2002","journal-title":"Journal of Human Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1373\/clinchem.2004.038737","article-title":"Statin therapy has no significant effect on skin tissue cholesterol: results from a prospective randomized trial","volume":"51","author":"Reiter","year":"2005","journal-title":"Clinical Chemistry"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ndt\/16.1.141","article-title":"Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients","volume":"16","author":"Renders","year":"2001","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijcard.2005.08.032","article-title":"The effect of atorvastatin on heart rate variability and lipoproteins in patients treated with coronary bypass surgery","volume":"111","author":"Riahi","year":"2006","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/dc08-1681","article-title":"Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study","volume":"32","author":"Rosenson","year":"2009","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/keq003","article-title":"Lack of effect of 8 weeks atorvastatin on microvascular endothelial function in patients with systemic sclerosis","volume":"49","author":"Sadik","year":"2010","journal-title":"Rheumatology"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD013211.pub2-BIB0199|cit199","first-page":"243","article-title":"The effect of statins in erectile dysfunction","volume":"17","author":"Samentzas","year":"2015","journal-title":"European Journal of Heart Failure"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajg.2011.04.008","article-title":"Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin","volume":"12","author":"Samy","year":"2011","journal-title":"Arab Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/107602960200800310","article-title":"Effects of atorvastatin treatment on sICAM-1 and plasma nitric oxide levels in hypercholesterolemic subjects","volume":"8","author":"Sardo","year":"2002","journal-title":"Clinical & Applied Thrombosis\/Hemostasis"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1185\/030079905X45170","article-title":"Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients","volume":"21","author":"Sardo","year":"2005","journal-title":"Current Medical Research & Opinion"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1532\/HSF98.20091185","article-title":"The effect of statin therapy on stimulation of endothelium-derived nitric oxide before and after coronary artery bypass surgery","volume":"13","author":"Sasmazel","year":"2010","journal-title":"Heart Surgery Forum"},{"issue":"JUN","key":"10.1002\/14651858.CD013211.pub2-BIB0204|cit204","first-page":"Article Number:","article-title":"The effect of atorvastatin (and subsequent metformin) on adipose tissue acylation-stimulatory-protein concentration and inflammatory biomarkers in overweight\/obese women with polycystic ovary syndrome","volume":"10","author":"Sathyapalan","year":"2019","journal-title":"Frontiers in Endocrinology"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0002-9149(02)02591-2","article-title":"Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects","volume":"90","author":"Schaefer","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.amjcard.2003.09.008","article-title":"Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects","volume":"93","author":"Schaefer","year":"2004","journal-title":"American Journal of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.amjcard.2005.01.023","article-title":"Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects","volume":"95","author":"Schaefer","year":"2005","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.30645","article-title":"Use of atorvastatin in systemic lupus erythematosus in children and adolescents","volume":"64","author":"Schanberg","year":"2012","journal-title":"Arthritis & Rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.atherosclerosis.2004.04.003","article-title":"Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo","volume":"175","author":"Schneider","year":"2004","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/107424849800300204","article-title":"A multicenter, placebo-controlled, dose-ranging study of atorvastatin","volume":"3","author":"Schrott","year":"1998","journal-title":"Journal of Cardiovascular Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ahj.2007.10.025","article-title":"A 6 month randomized, double blind, placebo controlled, multi-center trial of high dose atorvastatin on myocardial perfusion abnormalities by positron emission tomography in coronary artery disease","volume":"155","author":"Sdringola","year":"2008","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9149(03)00456-9","article-title":"Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction","volume":"92","author":"See","year":"2003","journal-title":"American Journal of Cardiology"},{"issue":"9364","key":"10.1002\/14651858.CD013211.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trials-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"issue":"5A","key":"10.1002\/14651858.CD013211.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"39F","DOI":"10.1016\/j.amjcard.2005.06.025","article-title":"Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA)","volume":"96","author":"Sever","year":"2005","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/HJH.0b013e328326cb1a","article-title":"Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension","volume":"27","author":"Sever","year":"2010","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0216|cit216","unstructured":"Sharma AK SPARCL Study. A double-blind, randomised, placebo-controlled study of Atorvastatin as prevention of cerebrovascular events in patients with a previous transient ischaemic attack or stroke National Research Register. Issue 1 2001"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0217|cit217","first-page":"457","article-title":"Atorvastatin treatment in patients with carotid stenosis is associated with a marked reduction in the risk of stroke, cardiac events and endarterectomy: a substudy of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial","volume":"38","author":"Sillesen","year":"2007","journal-title":"Stroke; a journal of cerebral circulation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013211.pub2-BIB0218|cit218","first-page":"55","article-title":"Atorvastatin treatment in patients with carotid stenosis is associated with a marked reduction in the risk of stroke, cardiovascular events and carotid revascularisation procedures. A substudy of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial","volume":"23","author":"Sillesen","year":"2007","journal-title":"Cerebrovascular diseases (basel, switzerland)"},{"issue":"12","key":"10.1002\/14651858.CD013211.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1161\/STROKEAHA.108.516450","article-title":"Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial","volume":"39","author":"Sillesen","year":"2008","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.amjcard.2008.03.057","article-title":"Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome","volume":"102","author":"Singh","year":"2008","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0221|cit221","first-page":"613","article-title":"Atorvastatin reduces sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolaemia and systemic arterial hypertension","volume":"67","author":"Sinski","year":"2009","journal-title":"Kardiologia Polska"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0021-9150(02)00428-8","article-title":"The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease","volume":"167","author":"Soedamah-Muthu","year":"2003","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s00125-015-3586-8","article-title":"Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial DBP - 20150422","volume":"58","author":"Soedamah-Muthu","year":"2015","journal-title":"Diabetologia"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jacc.2005.06.088","article-title":"Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure","volume":"47","author":"Sola","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2796.2006.01608.x","article-title":"Composition of coronary plaques obtained by directional atherectomy in stable angina: its relation to serum lipids and statin treatment","volume":"259","author":"Solem","year":"2006","journal-title":"Journal of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1567205054367900","article-title":"Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD","volume":"2","author":"Sparks","year":"2005","journal-title":"Current Alzheimer Research"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0021-9150(02)00334-9","article-title":"Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins","volume":"166","author":"Sposito","year":"2003","journal-title":"Atherosclerosis"},{"issue":"24","key":"10.1002\/14651858.CD013211.pub2-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/eurheartj\/ehi482","article-title":"A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study","volume":"26","author":"Stalenhoef","year":"2005","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijcard.2007.11.025","article-title":"Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation","volume":"133","author":"Stefanadi","year":"2009","journal-title":"International Journal of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD013211.pub2-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1105803","article-title":"Effect of a monoclonal antibody to PCSK9 on LDL cholesterol","volume":"366","author":"Stein","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2004.10.009","article-title":"Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure","volume":"179","author":"Strey","year":"2005","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1002\/14651858.CD013211.pub2-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1136\/hrt.2005.082560","article-title":"Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure","volume":"92","author":"Strey","year":"2006","journal-title":"Heart"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.hrthm.2011.09.016","article-title":"Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial","volume":"9","author":"Suleiman","year":"2012","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijcard.2006.05.043","article-title":"The effect of rapid lipid lowering with atorvastatin on autonomic parameters in patients with coronary artery disease","volume":"117","author":"Szramka","year":"2007","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem.87.2.8249","article-title":"Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus","volume":"87","author":"Tan","year":"2002","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"1-2","key":"10.1002\/14651858.CD013211.pub2-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0009-8981(01)00589-7","article-title":"A double-blind trial on the effects of atorvastatin on glycemic control in Japanese diabetic patients with hypercholesterolemia","volume":"312","author":"Tanaka","year":"2001","journal-title":"Clinica Chimica Acta"},{"issue":"10","key":"10.1002\/14651858.CD013211.pub2-BIB0237|cit237","first-page":"1631","article-title":"Effect of atorvastatin on lipid profile and blood glucose level in hypercholesterolemic type 2 diabetic patients","volume":"30","author":"Tanaka","year":"2009","journal-title":"Therapeutic Research"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.amjcard.2005.10.032","article-title":"Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal","volume":"97","author":"Taneva","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1055\/s-0037-1614841","article-title":"Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects","volume":"82","author":"Tannous","year":"1999","journal-title":"Thrombosis & Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2004.08.007","article-title":"Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women","volume":"120","author":"Tanriverdi","year":"2005","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0241|cit241","first-page":"399","article-title":"Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level","volume":"88","author":"Tantikosoom","year":"2005","journal-title":"Chotmaihet Thangphaet [Journal of the Medical Association of Thailand]"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1016\/j.thromres.2010.05.023","article-title":"Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia","volume":"126","author":"Tehrani","year":"2010","journal-title":"Thrombosis Research"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jjcc.2008.08.008","article-title":"Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction","volume":"53","author":"Teshima","year":"2009","journal-title":"Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2004.08.037","article-title":"Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure","volume":"178","author":"Tousoulis","year":"2005","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/hrt.2003.027110","article-title":"Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure","volume":"91","author":"Tousoulis","year":"2005","journal-title":"Heart"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.ejheart.2005.03.007","article-title":"Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure","volume":"7","author":"Tousoulis","year":"2005","journal-title":"European Journal of Heart Failure"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijcard.2005.05.055","article-title":"The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level","volume":"109","author":"Tousoulis","year":"2006","journal-title":"International Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijcard.2005.02.011","article-title":"Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina","volume":"106","author":"Tousoulis","year":"2006","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/hrt.2006.093112","article-title":"Effects of atorvastatin and vitamin C on forearm hyperaemic blood flow, asymmentrical dimethylarginine levels and the inflammatory process in patients with type 2 diabetes mellitus","volume":"93","author":"Tousoulis","year":"2007","journal-title":"Heart"},{"issue":"10","key":"10.1002\/14651858.CD013211.pub2-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.clinthera.2010.09.007","article-title":"Impact of 6 weeks of treatment with low-dose metformin and atorvastatin on glucose-induced changes of endothelial function in adults with newly diagnosed type 2 diabetes mellitus: A single-blind study","volume":"32","author":"Tousoulis","year":"2010","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2009.11.038","article-title":"Combined effects of atorvastatin and metformin on glucose-induced variations of inflammatory process in patients with diabetes mellitus","volume":"149","author":"Tousoulis","year":"2011","journal-title":"International Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0252|cit252","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1194\/jlr.M011080","article-title":"Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men","volume":"52","author":"Tremblay","year":"2011","journal-title":"Journal of Lipid Research"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0253|cit253","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ahj.2008.01.028","article-title":"Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial","volume":"156","author":"Tsai","year":"2008","journal-title":"American Heart Journal"},{"issue":"12","key":"10.1002\/14651858.CD013211.pub2-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.ATV.0000190608.28704.71","article-title":"Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins","volume":"25","author":"Urso","year":"2005","journal-title":"Arteriosclerosis, Thrombosis & Vascular Biology"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0021-9150(02)00316-7","article-title":"Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus","volume":"166","author":"de Ree","year":"2003","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1002\/14651858.CD013211.pub2-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1046\/j.1538-7836.2003.00357.x","article-title":"Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus","volume":"1","author":"Van De Ree","year":"2003","journal-title":"Journal of Thrombosis & Haemostasis"},{"issue":"10","key":"10.1002\/14651858.CD013211.pub2-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.amjcard.2005.07.052","article-title":"Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease","volume":"96","author":"Harst","year":"2005","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/ajcn\/84.6.1324","article-title":"Effect of garlic powder on C-reactive protein and plasma lipids in overweight and smoking subjects","volume":"84","author":"Doorn","year":"2006","journal-title":"American Journal of Clinical Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1185\/03007990802596813","article-title":"Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes","volume":"25","author":"Hoek","year":"2009","journal-title":"Current Medical Research & Opinion"},{"issue":"11","key":"10.1002\/14651858.CD013211.pub2-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0002-9149(02)02333-0","article-title":"Comparison of extended-release niacin and atorvastatin mono-therapies and combination treatment of the atherogenic lipid profile in diabetes mellitus","volume":"89","author":"Van","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2143\/AC.56.3.2005634","article-title":"The effect of atorvastatin on postprandial lipidaemia in overweight or obese women homozygous for apo E3","volume":"56","author":"Vansant","year":"2001","journal-title":"Acta Cardiologica"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2337\/diacare.25.7.1211","article-title":"Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial","volume":"25","author":"Venrooij","year":"2002","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2337\/diacare.26.4.1216","article-title":"Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes","volume":"26","author":"Venrooij","year":"2003","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2003.11.008","article-title":"Does atorvastatin influence serum C-reactive protein levels in patients on long-term hemodialysis?","volume":"43","author":"Vernaglione","year":"2004","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2265.2008.03412.x","article-title":"Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes","volume":"71","author":"Eynatten","year":"2009","journal-title":"Clinical Endocrinology"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cardfail.2005.06.439","article-title":"Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure","volume":"11","author":"Vrtovec","year":"2005","journal-title":"Journal of Cardiac Failure"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1536\/jhj.42.725","article-title":"A randomized, double-blind, placebo-controlled, 8-week study to evaluate the efficacy and safety of once daily atorvastatin (10 mg) in patients with elevated LDL-cholesterol","volume":"42","author":"Wang","year":"2001","journal-title":"Japanese Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjcard.2003.09.018","article-title":"Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg\/dl","volume":"93","author":"Wassmann","year":"2004","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0270|cit270","first-page":"26","article-title":"Comparison of aggressive lipid lowering with Atorvastatin vs. Revascularization Treatments (AVERT) and conventional care for the reduction of ischemic events in patients with stable coronary artery disease","volume":"21","author":"Waters","year":"2000","journal-title":"Cardiovascular Reviews & Reports"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2337\/diabetes.52.3.803","article-title":"Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome","volume":"52","author":"Watts","year":"2003","journal-title":"Diabetes"},{"issue":"7","key":"10.1002\/14651858.CD013211.pub2-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.ijo.0802287","article-title":"Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome","volume":"27","author":"Watts","year":"2003","journal-title":"International Journal of Obesity & Related Metabolic Disorders: Journal of the International Association for the Study of Obesity"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/CIRCULATIONAHA.108.785915","article-title":"Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study","volume":"119","author":"Williams","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.tp.0000235446.50715.ef","article-title":"Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation","volume":"82","author":"Wissing","year":"2006","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.amjcard.2005.09.142","article-title":"Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels","volume":"97","author":"Wojnicz","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"31","key":"10.1002\/14651858.CD013211.pub2-BIB0276|cit276","first-page":"2215","article-title":"[Effect of atorvastatin on carotid intima-medial of thickness of primary hypertension patients of Han nationality in China]. [Chinese]","volume":"87","author":"Wu","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0277|cit277","first-page":"189","article-title":"[Effects of low-dose atorvastatin in combination with aspirin on carotid atherosclerotic plaques and blood biochemical parameters in patients with cerebral infarction]","volume":"6","author":"Xia","year":"2009","journal-title":"Chinese Journal of Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijcard.2008.11.030","article-title":"Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure","volume":"140","author":"Xie","year":"2010","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"1055.e1","DOI":"10.1016\/j.ahj.2007.03.027","article-title":"Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study","volume":"153","author":"Yamada","year":"2007","journal-title":"American Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000235746","article-title":"Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound","volume":"28","author":"Yamada","year":"2009","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ahj.2005.03.059","article-title":"Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study","volume":"150","author":"Yokoyama","year":"2005","journal-title":"American Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejheart.2008.03.010","article-title":"Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure","volume":"10","author":"Young","year":"2008","journal-title":"European Journal of Heart Failure"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1183\/09031936.00149011","article-title":"Atorvastatin in pulmonary arterial hypertension (Apath) Study","volume":"40","author":"Zeng","year":"2012","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0284|cit284","first-page":"1314","article-title":"Effect of atorvastatin combined with Tongxinluo capsule on intra-media thickness of common carotid artery 91 patients with primary hypertension","volume":"9","author":"Zhang","year":"2009","journal-title":"China Tropical Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0285|cit285","first-page":"46","article-title":"Effects of different doses of atorvastatin on lipid levels and nervous function in patients with acute cerebral infarction. [Chinese]","volume":"9","author":"Zhang","year":"2009","journal-title":"Chinese Journal of Contemporary Neurology and Neurosurgery"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0286|cit286","first-page":"2381","article-title":"Effects of atorvastatin on growth differentiation factor 15, brain natriuretic peptide, cardiac troponin I and adiponectin in patients with acute myocardial infarction","volume":"35","author":"Zheng","year":"2019","journal-title":"Acta Medica Mediterranea"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0287|cit287","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008226.pub3","article-title":"Atorvastatin for lowering lipids","author":"Adams","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0288|cit288","unstructured":"atorvastatin Adverse Reactions - Epocrates Online https:\/\/online.epocrates.com\/drugs\/87805\/atorvastatin\/Adverse-Reactions"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD013211.pub2-BIB0289|cit289","first-page":"S9","article-title":"Testosterone replacement in men with andropause: an overview","volume":"6","author":"Brawer","year":"2004","journal-title":"Reviews in Urology"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0290|cit290","unstructured":"Chapter 16: Special topics in statistics.In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0291|cit291","unstructured":"Chapter 8: Assessing risk of bias in included studies. In Julian PT Higgins, Douglas G Altman and Jonathan AC Sterne, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0292|cit292","unstructured":"Covidence systematic review software Veritas Health InnovationCovidence Veritas Health Innovation 2018"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0293|cit293","unstructured":"Data Extraction and Assessment Template https:\/\/training.cochrane.org\/sites\/training.cochrane.org\/files\/public\/uploads\/resources\/downloadable_resources\/English\/Collecting%20data%20-%20form%20for%20RCTs%20only.doc 2011"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.maturitas.2010.04.019","article-title":"Androgen deficiency in women; role of accurate testosterone measurements","volume":"67","author":"Demers","year":"2010","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1210\/jcem-53-1-58","article-title":"Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma","volume":"53","author":"Dunn","year":"1981","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0296|cit296","unstructured":"Center for Drug Evaluation and Research Atorvastatin calcium tablets for oral administration (approval package) www.accessdata.fda.gov\/drugsatfda_docs\/anda\/2011\/076477Orig1s000.pdf 2011"},{"issue":"2","key":"10.1002\/14651858.CD013211.pub2-BIB0297|cit297","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","article-title":"Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study","volume":"87","author":"Feldman","year":"2002","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"11","key":"10.1002\/14651858.CD013211.pub2-BIB0298|cit298","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1206168","article-title":"Gonadal steroids and body composition, strength, and sexual function in men","volume":"369","author":"Finkelstein","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0300|cit300","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2015"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0301|cit301","first-page":"20","article-title":"Population health impact of statin treatment in Canada","volume":"27","author":"Hennessy","year":"2016","journal-title":"Health Reports"},{"issue":"11","key":"10.1002\/14651858.CD013211.pub2-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0303|cit303","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0304|cit304","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jama.2013.284657","article-title":"More than a billion people taking statins? Potential implications of the new cardiovascular guidelines","volume":"311","author":"Ioannidis","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0305|cit305","unstructured":"IQVIA Institute for Human Data Science Medicines use and spending in the U.S. A Review of 2016 and Outlook to 2021 www.iqvia.com\/institute\/reports\/medicines-use-and-spending-in-the-us-a-review-of-2016 2017"},{"issue":"5","key":"10.1002\/14651858.CD013211.pub2-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"471","DOI":"10.21215\/kjfp.2019.9.5.471","article-title":"A case report of gynecomastia due to rosuvastatin","volume":"9","year":"2019","journal-title":"Korean Journal of Family Practice"},{"issue":"11","key":"10.1002\/14651858.CD013211.pub2-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0025-6196(11)60671-X","article-title":"Gynecomastia: Pathophysiology, Evaluation, and Management","volume":"84","author":"Johnson Ruth","year":"2009","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0308|cit308","doi-asserted-by":"crossref","unstructured":"Altman Douglas G G\u00c3\u00b8tzsche Peter C Ioannidis John PA The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ (Clinical research ed.) 2009 339","DOI":"10.1136\/bmj.b2700"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0309|cit309","volume-title":"Mosby's Diagnostic and Laboratory Test Reference","author":"Pagana","year":"2015"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0310|cit310","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"6","key":"10.1002\/14651858.CD013211.pub2-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00228-012-1218-5","article-title":"Statin-associated gynecomastia: Evidence coming from the Italian spontaneous ADR reporting database and literature","volume":"68","year":"2012","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD013211.pub2-BIB0312|cit312","first-page":"39","article-title":"An overview of cholesterol management","volume":"1","author":"Schaiff","year":"2008","journal-title":"American Health & Drug Benefits"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"105439","DOI":"10.1016\/j.jsbmb.2019.105439","article-title":"Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review","volume":"194","author":"Baranowski Elizabeth","year":"2019","journal-title":"The Journal of steroid biochemistry and molecular biology"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0314|cit314","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1741-7015-11-57","article-title":"The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Schooling","year":"2013","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0315|cit315","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0316|cit316","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2019Summary of findings\u2019 tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0317|cit317","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A GRADE handbook for grading quality of evidence and strength of recommendations Available from guidelinedevelopment.org\/handbook 2013"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0318|cit318","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/cen.13794","article-title":"Statin medications and the risk of gynecomastia","volume":"89","author":"Skeldon","year":"2018","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0319|cit319","volume-title":"Medicinal Chemistry","year":"2010"},{"issue":"4","key":"10.1002\/14651858.CD013211.pub2-BIB0320|cit320","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: mechanism of action and effects","volume":"5","author":"Stancu","year":"2001","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0321|cit321","first-page":"25","article-title":"Testosterone for the aging male; current evidence and recommended practice","volume":"3","author":"Stanworth","year":"2008","journal-title":"Clinical Interventions in Aging"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0322|cit322","unstructured":"Sterne JA Egger M Moher D Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"25 Pt B","key":"10.1002\/14651858.CD013211.pub2-BIB0323|cit323","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults","volume":"63","author":"Stone","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0324|cit324","doi-asserted-by":"crossref","first-page":"e007280","DOI":"10.1136\/bmjopen-2014-007280","article-title":"An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials","volume":"5","author":"Sun","year":"2015","journal-title":"BMJ Open"},{"issue":"20","key":"10.1002\/14651858.CD013211.pub2-BIB0325|cit325","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-associated side effects","volume":"67","author":"Thompson","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD013211.pub2-BIB0326|cit326","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2164\/jandrol.108.005215","article-title":"The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction","volume":"30","author":"Traish Abdulmaged","year":"2009","journal-title":"Journal of andrology"},{"issue":"3","key":"10.1002\/14651858.CD013211.pub2-BIB0327|cit327","first-page":"288","article-title":"Statins in the primary and secondary prevention of cardiovascular disease in women: Facts and myths","volume":"40","author":"Virani Salim","journal-title":"Texas Heart Institute Journal"},{"issue":"12","key":"10.1002\/14651858.CD013211.pub2-BIB0328|cit328","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5414\/CPP41567","article-title":"Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials","volume":"41","author":"Vrecer","year":"2003","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0329|cit329","doi-asserted-by":"publisher","first-page":"590","DOI":"10.12659\/MSM.914128","article-title":"The Effect of Statins on Levels of Dehydroepiandrosterone (DHEA) in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis","volume":"25","author":"Yang","year":"2019","journal-title":"Medical Science Monitor"},{"key":"10.1002\/14651858.CD013211.pub2-BIB0330|cit330","unstructured":"Effect of atorvastatin on testosterone levels Cochrane Database of Systematic Reviews 2018 12 10.1002\/14651858.CD013211"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T22:54:09Z","timestamp":1761260049000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013211.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":330,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013211.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]}}}